Jiangxi Rimag Group (HKG:2522) incurred an attributable loss of 45.9 million yuan in 2024, compared with an attributable profit of 44.4 million yuan in the year-ago period, a March 28 filing with the Hong Kong bourse said.
Loss per share was 0.132 yuan, whereas the company had made earnings per share of 0.131 yuan in 2023.
The medical imaging solution services company's revenue fell by 18% to 760.6 million yuan in the year from 928.9 million yuan a year prior.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.